David Gregornik, BS, PharmD, BCOP, Director, Pharmacogenomics Program, presented and moderated a panel discussion at the University of Minnesota Biennial Pharmacogenomics Conference. The event was
The pharmacogenomics program at Children’s Minnesota utilizes molecular testing to analyze genes in order to understand how a patient will metabolize medications.
Learn more about the Children’s Minnesota pharmacogenomics program and how it helps find safer medications for patients.
Reach us 24/7 for patient referrals, consults, admissions and neonatal transport.
© 2024 Children’s Minnesota
Children’s Minnesota is registered as a 501(c)(3) non-profit organization. Our tax identification number is 41-1754276.
